Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,666,667
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
32,464,182
-
Shares change
-
+2,373,396
-
Total reported value, excl. options
-
$178,189,764
-
Value change
-
+$13,240,245
-
Put/Call ratio
-
0.71%
-
Number of buys
-
67
-
Number of sells
-
26
-
Price
-
$5.49
Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q2 2023
As of 30 Jun 2023 HARVARD BIOSCIENCE INC - Common Stock (HBIO) had 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 32,464,182 shares of stock of the company.
Largest 10 holders included B. Riley Asset Management, LLC, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., BlackRock Inc., Harvey Partners, LLC, AMH Equity Ltd, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, Granahan Investment Management, LLC, ROYCE & ASSOCIATES LP, and BOOTHBAY FUND MANAGEMENT, LLC.
This table shows 110 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.